(R)-CSN5i-3 manufacturers
- (R)-CSN5i-3
-
- $159.00
-
2026-07-15
- CAS:2863607-74-1
- Purity: 99.97%
- Supply Ability: 10g
- (R)-CSN5i-3
-
- $159.00
-
2026-07-15
- CAS:2863607-74-1
- Purity: 99.97%
- Supply Ability: 10g
|
| | (R)-CSN5i-3 Basic information |
| Product Name: | (R)-CSN5i-3 | | Synonyms: | (R)-CSN5i-3;1H-Pyrazole-5-carboxamide, 3-(difluoromethyl)-1-(1-methylethyl)-N-[6-[(5R,6R)-6,7,8,9-tetrahydro-6-hydroxy-5H-imidazo[1,5-a]azepin-5-yl][1,1′-biphenyl]-3-yl]-;CSN5i-3-NEG | | CAS: | 2863607-74-1 | | MF: | C28H29F2N5O2 | | MW: | 505.56 | | EINECS: | | | Product Categories: | | | Mol File: | 2863607-74-1.mol |  |
| | (R)-CSN5i-3 Chemical Properties |
| Boiling point | 666.5±55.0 °C(predicted) | | density | 1.35±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | form | Solid | | pka | 12.66±0.70(predicted) | | color | White to off-white |
| | (R)-CSN5i-3 Usage And Synthesis |
| Uses | (R)-CSN5i-3 is the (R)-enantiomer of CSN5i-3. CSN5i-3 is a potent, selective and orally available inhibitor of CSN5[1]. | | References | [1] Schlierf A, et al. Targeted inhibition of the COP9 signalosome for treatment of cancer. Nat Commun. 2016 Oct 24;7:13166. DOI:10.1038/ncomms13166 |
| | (R)-CSN5i-3 Preparation Products And Raw materials |
|